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Background 
 Pig production diseases usually originate from a complex interaction 
of pathogens, animal genetics and environment.  
 Although production diseases can have a substantial impact on farm 
economics, their overall impacts are not very well known. 
 Changes in animal health can have wider societal consequences for 
instance due to their contribution to animal welfare and antimicrobial 
resistance  
 The aim of this presentation is to share information about the costs 
and financial impacts of production diseases in pigs 
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The economic impacts of diseases fall into four areas 
 The incidence, severity and costs of disease can vary by case  
 The costs of preventive measures are incurred before potential benefits are observed 
 Incentives to reduce disease risks may change as the risk of disease changes 
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Additional revenues 
How have we arrived at our estimates? 
 A systematic review of 130 studies published in the period 1995-
2015 and dealing with financial impacts of production diseases 
 Consultation of altogether 55 stakeholders in five countries (DE, ES, 
FI, PL, UK) who were asked about the validity of cost estimates 
generated by the review and about financial significance of these 
diseases in pigs 
Modelling specific interventions by using data originating from 
PROHEALTH experiments 
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Why bother about production diseases? 
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Three principal economic reasons why  
an intervention can be adopted 
 It reduces production costs per unit of output leading to economic 
gains, without affecting demand for the product at a given price. 
 It increases demand for the product, which associated with 
consumers’ willing to pay a premium for the product because the 
intervention 
 Policy measures or coordinated actions provide additional incentives 
which encourage farmers to adopt the measure. 
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Production diseases can cost up to €30-40 per pig 
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The most important production disease categories  
economically according to stakeholders 
 In sows 
1. Reproductive disorders   
2. Locomotory disorders   
3. Gastrointestinal disorders   
 
 In weaners, grower and fattening pigs  
1. Respiratory disorders   
2. Gastrointestinal disorders   
3. Locomotory disorders   
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Stakeholder views whether a specific disease was among  
the top three disorders economically in sows 
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Stakeholder views whether a specific disease was among  
the top three disorders economically in growers and fatteners 
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Respiratory disorders 
 Respiratory diseases are common in pigs in Europe and 
economically an important issue! 
 Financial losses due to porcine respiratory disease complex were 
estimated at about €6.8 per fattening pig averaged over the affected 
herd. 
 Depending on pathogen and case, the losses ranged from €2 to €19 
per fattening pig produced. 
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Mortality 
 Overall, mortality was estimated to cost €3-€9 per marketed pig 
 The costs of pre-weaning mortality, including also mortality combined 
with diarrhea, were at least between €2 and €5 per sold piglet.  
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Enteric disorders 
 Diarrhea is an important and common health problem in piglets 
 The cost of post-weaning enteric diseases were typically €3-4 per 
finished pig (range up to €12.7 per piglet) 
 The costs of ileitis were €7.1 per affected pig (range up to €25), 
• Some stakeholders considered the costs to be higher, but studies 
have also reported higher costs in the past than more recently. 
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Other disorders 
 The costs of tail biting in fattening pigs were €2 per produced pig, 
although some stakeholders considered the costs to be higher 
 
 The costs of non-treated parasite Ascaris suum in pigs were on 
average €6.9 per pig 
 
17 
18 
Porcine 
respiratory 
disease 
complex 
Pre-
weaning 
mortality 
Post-
wean 
enteric 
disease 
Tail 
biting 
Untreated 
Ascaris 
suum 
Mortality 
(overall) 
Locomotory disorders 
 Lameness in finishing pigs was estimated to cost €12 to €67 per 
lame finishing pig, depending on the cause of lameness. This was 
based on small number of studies only 
 
 Lameness in sows 
Typically 9-15% of sows, or even more, are removed due to 
locomotory disorders 
The costs of lameness ranged from €145 to €330 per lame sow.  
 
 Some stakeholders considered these cost high 
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Reproductive disorders 
 The costs of the complex syndrome ‘Mastitis, Metritis and Agalactia’ 
were estimated to range at least up to €95 per affected sow, althoug 
in the most severe cases the losses could range up to €470 per 
diseased sow. 
 Typically 21-35% of sows are removed due to reproductive failures, 
and the costs of premature replacement due to disorders in 
reproduction were €148-€167 per replaced sow 
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To which extent interventions can 
recover the costs? 
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Case study: disease associated with  
poor hygiene in pig fattening 
 Lower growth rate 
 Altered feed consumption 
 Elevated incidence of respiratory lesions 
 Annually, up to 18% less pigmeat per pig space 
 Substantial financial losses, up to €15-23 per pig, 
which reduce farm income 
 Disease costs correspond to 3-5% of consumer 
price 
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What about societal costs? 
 The public acknowledges some of the benefits of intensive 
production, relating mainly to benefits to themselves, such as lower 
food price and improved availability 
 However, they also have worries which are related to naturalness, 
animal welfare and food safety concerns, antimicrobial usage and 
risk of increased animal disease incidence 
 Consumers associate animal friendly products with improved product 
quality, safety and healthiness (Clark et al. 2016) 
 
 
25 
What about societal costs? 
 The public appear to have little knowledge of production diseases 
and their mitigation strategies (Clark et al. 2016) 
 More proactive provision of information is needed 
 Literature shows a willingness to pay (WTP) more for animal-friendly 
products, but WTP varies by region.  
 Tendency to prefer natural and proactive interventions to control 
for production diseases ― reactive and “treatment-based” 
interventions are viewed as less acceptable 
Preventive interventions related to housing, biosecurity, nutrition 
and other management are likely to be perceived positively 
Potential for business benefits through quality assurance schemes 
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Production diseases can cost up to €30 - €40 per pig 
 Overall, respiratory, reproductive and gastrointestinal diseases and 
mortality were the most important production diseases economically.  
 Production diseases cost money - even when the diseases are 
controlled 
 Biosecurity and hygiene are important! 
 Interventions are not economically viable per se - the financial 
effects of both disease and disease prevention vary case by case.  
 Stakeholders and consumers prefer preventive interventions 
 Production systems tend to be vertically integrated, which provides 
opportunities to adopt interventions and to look at animal health 
from the system’s perspective.  
 Effective control of production diseases can benefit the consumer! 
 
 
27 
Contact: 
 
Jarkko Niemi 
Natural Resources Institute Finland (Luke) 
 
Mobile:  +358 40 358 0487 
Email:    jarkko.niemi@luke.fi 
Twitter:  @Jarkko_Niemi 
 
www.fp7-prohealth.eu 
 
 
 
 
 
 
 
28 
This project has received funding from the European Union’s 
Seventh Framework Programme for research, technological 
development and demonstration under grant agreement no 613574. 
